[Pharmacological treatment in the initial period of ischemic stroke].
Członkowska
A
A
Kliniki Chorób Naczyniowych Układu Nerwowego, Instytutu Psychiatrii i Neurologii w Warszawie.
D000925:Anticoagulants / Q000008:administration & dosage*; D002545:Brain Ischemia / Q000150:complications*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013997:Time Factors
D000925:Anticoagulants; D002317:Cardiovascular Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
Leczenie farmakologiczne w poczatkowym okresie udaru niedokrwiennego.